Reference

Ultrastructural aspects of liver cell hypertrophy

Ultrastructural aspects of liver cell hypertrophy. Shkurupii, V. A.; Gavrilin, V. N.; Kovrigina, G. G. (Novosib. Med. Inst., Novosibirsk, USSR). Eksp. Med. (Riga), 17, 148-2 (Russian) 1984. CODEN: EKMEDL. DOCUMENT TYPE: Journal CA Section: 4 (Toxicology) Hypertrophy of hepatocytes and their organelles (lysosomes, mitochondria, cell nucleus peroxisomes, rough endoplasmic reticulum, and liposomes) and Kupfer cells was usually obsd. in mice after a 10-min inhalation of CCl4 [56-23-5] or i.v. injection of Fe saccharate [8047-67-4] and in rats after i.p. injection of PVP [9003-39-8]. Apparently, this is due to functional overload during the removal of substances from circulation.

Combination of erythropoietin and iron(III) complex for treatment of hemodialysis patients

Combination of erythropoietin and iron(III) complex for treatment of hemodialysis patients.Some chemicals with cas registry numbers like 8047-67-4 and 20074-52-6 are also used. Lehmann, Paul (Boehringer Mannheim Gmbh, Germany). Ger. Offen. DE 19535571 A1 20 Mar 1997, 4 pp. (German). (Germany). CODEN: GWXXBX. CLASS: ICM: A61K038-18. ICS: A61J003-00. APPLICATION: DE 1995-19535571 14 Sep 1995. DOCUMENT TYPE: Patent CA Section: 18 (Animal Nutrition) Section cross-reference(s): 2, 63 The high Fe requirement of hemodialysis patients is provided by i.v. coadministration, in the same prepn. or sep. prepns., of recombinant human erythropoietin (3000-7000 IU) and a Fe3+ complex [e.g. Fe gluconate or Fe(OH)3 saccharate at 5-20 mg]. Use of this low concn. of Fe3+ complex avoids Fe toxicity and acute-phase reactions. .